Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating NDI-034858 in active psoriatic arthritis has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• NDI-034858

Snippet

Sponsor: Takeda | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2024-05-31